Subscribe To
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
CHARLOTTESVILLE, Va. and CARMEL, Ind., July 17, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced that it has commenced an underwritten public offering of $100 million of shares of its […] The post Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock appeared first on For...
Read More
Posted: Jul 17 2023, 20:53
Author Name: forextv
Views: 080933